Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group Identifier:
First received: October 3, 2003
Last updated: February 12, 2014
Last verified: February 2014